How is the Apellis Pharmaceuticals Inc today?

The Apellis Pharmaceuticals Inc today is trading in the green, up by 13.05% at 19.14.

How has Apellis Pharmaceuticals Inc performed historically?

The Apellis Pharmaceuticals Inc is currently trading up 13.05% on an intraday basis in the past week the index rose 9.75%. The index has been down -23.90% in the past quarter and fell -51.24% in the past year. You can view this in the overview section.

What is Apellis Pharmaceuticals Inc Annual Revenue?

Apellis Pharmaceuticals Inc Annual Revenue rose 97.02%, in the last year to $781.37 M. Its sector's average revenue growth for the last fiscal year was 8.76%.

What is Apellis Pharmaceuticals Inc Annual Net Profit?

Apellis Pharmaceuticals Inc Annual Net Profit rose 62.57% in the last year to $197.88 M. Its sector's average net profit growth for the last fiscal year was -12.66%.

What is Apellis Pharmaceuticals Inc Price to Earning Ratio?

Apellis Pharmaceuticals Inc Price to Earning Ratio is -10.75, which is negative.

What is Apellis Pharmaceuticals Inc Stock Price?

Apellis Pharmaceuticals Inc Stock Price fell 51.24% and underperformed its sector by 89.83% in the past year.

What is Apellis Pharmaceuticals Inc Quarterly Revenue?

Apellis Pharmaceuticals Inc Quarterly Revenue fell 3.21% YoY to $166.8 M. Its sector's average revenue growth YoY for the quarter was 3.14%.

What is Apellis Pharmaceuticals Inc Quarterly Net profit?

Apellis Pharmaceuticals Inc Quarterly Net profit fell 38.84% YoY to $92.22 M. Its sector's average net profit growth YoY for the quarter was -235.97%.

What is Apellis Pharmaceuticals Inc Debt to Equity Ratio?

Apellis Pharmaceuticals Inc Debt to Equity Ratio of 2.06 is higher than 1. This implies that company assets are financed through debt.

What is Apellis Pharmaceuticals Inc Return on Equity(ROE)?

Apellis Pharmaceuticals Inc Return on Equity(ROE) for the last financial year was -93.55%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Apellis Pharmaceuticals Inc Mutual Fund Holding?

Apellis Pharmaceuticals Inc Mutual Fund Holding decreased by 0.29% in the last quarter to 43.3.

What is Apellis Pharmaceuticals Inc Promoter Share Holding?

Apellis Pharmaceuticals Inc Promoter Share Holding increased by 0.06% in the most recent quarter to 3.7%.

What is Apellis Pharmaceuticals Inc Interest Coverage Ratio?

Apellis Pharmaceuticals Inc Interest Coverage Ratio is -3.87, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is Apellis Pharmaceuticals Inc Institutional Holding?

Apellis Pharmaceuticals Inc Institutional Holding increased by 0.11% in the last quarter to 101.84.

Apellis Pharmaceuticals Inc XNAS: APLS

Apellis Pharmaceuticals Inc Live Share Price Today, Share Analysis and Chart

Name: Apellis Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Apellis Pharmaceuticals Inc
Rating: 1.415791625
Author: Trendlyne DVM scores

Weak Stock

about

Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement s...

19.14 2.21 (13.05%)

56.26% Fall from 52W High

6.2M XNAS Volume

High volume+gain today

XNAS 02 Jun, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for Apellis Pharmaceuticals Inc is on 05 Jun 2025 for the purpose of Apellis Pharmaceuticals Inc Annual General Meeting for 2025 See details

Low Financial Strength

33.3 / 100

Expensive Valuation

12.7 / 100

Technically Bearish

33.9 / 100

Weak Stock These stocks are the ones with poor quality, financials and technicals. This indicates that investors should be highly watchful with these stocks. View Similar Embed DVM

1Yr Price target upside is 90%

20 analysts

Apellis Pharmaceuticals Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Apellis Pharmaceuticals Inc Live Share Price Today, Share Analysis and Chart

Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement s...

56.26% Fall from 52W High

High volume+gain today

SWOT Analysis

Apellis Pharmaceuticals Inc Live Price Chart

Apellis Pharmaceuticals Inc FAQ

How is Apellis Pharmaceuticals Inc today?

Apellis Pharmaceuticals Inc today is trading in the green, and is up by 13.05% at 19.14.

How has Apellis Pharmaceuticals Inc performed historically?

Apellis Pharmaceuticals Inc is currently trading up 13.05% on an intraday basis. In the past week the stock rose 9.75%. stock has been down -23.90% in the past quarter and fell -51.24% in the past year. You can view this in the overview section.